Bosentan har været forbundet med dosisrelaterede forøgelser af leveraminotransferaser, dvs. aspartat - og alaninaminotransferaser.
Bosentan has been associated with dose-related elevations in liver aminotransferases, i.e., aspartate and alanine aminotransferases.